No record found
No record found
* Returns not adjusted for payouts
Company Profile
Shifa International Hospitals Limited was incorporated in Pakistan on September 29, 1987 as a private limited company under the repealed Companies Ordinance, 1984 and converted into a public limited company on October 12, 1989. The principal activity of the Company is to establish and run medical centers and hospitals in Pakistan. The Company is also running medical centers, pharmacies and Lab collection points in different cities of Pakistan.
Dr. Zeeshan Bin Ishtiaque | CEO |
Dr. Habib ur Rahman | Chairperson |
Muhammad Naeem | Company Secretary |
M/s Corplink (Private) Limited, Wings Arcade, 1-K, Commercial, Model Town, Lahore
BDO Ebrahim & Co. Chartered Accountants
June
Equity Profile
Announcements
Date | Title | Document |
---|---|---|
Oct 30, 2024 | Transmission of Quarterly Report for the Period Ended 2024-09-30 | View PDF |
Oct 28, 2024 | Financial Results for the 1st Quarter Ended September 30, 2024 | View PDF |
Oct 7, 2024 | Transmission of Annual Report for the Year Ended 2024-06-30 | View PDF |
Sep 16, 2024 | Financial Results for the Year Ended 2024-06-30 | View PDF |
Apr 30, 2024 | Transmission of Quarterly Report for the Period Ended March 31, 2024 | View PDF |
Apr 26, 2024 | Financial Results for the 3rd Quarter Ended 2024-03-31 | View PDF |
Mar 1, 2024 | Transmission of Quarterly Report for the Period Ended 2023-12-31 | View PDF |
Feb 29, 2024 | Transmission of Quarterly Report for the Period Ended 2023-12-31 REVOKED | View PDF |
Feb 26, 2024 | Financial Results for the 2nd Quarter (Half Year) Ended December 31, 2023 | View PDF |
Oct 30, 2023 | Transmission of Quarterly Report for the Period Ended 2023-09-30 | View PDF |
Date | Title | Document |
---|---|---|
Oct 28, 2024 | CERTIFIED COPY RESOLUTIONS PASSED BY THE SHAREHOLDERS IN THE 38TH ANNUAL GENERAL MEETING OF SHIFA INTERNATIONAL HOSPITALS LIMITED HELD ON OCTOBER 28, 2024 | View PDF |
Oct 18, 2024 | Board Meeting | View PDF |
Oct 7, 2024 | Notice of 38th Annual General Meeting 2024 | View PDF |
Sep 4, 2024 | Board Meeting | View PDF |
Jun 24, 2024 | Board Meeting other than Financial Results | View PDF |
Jun 20, 2024 | Certified Copy of Resollution Adopted in Extraordinary General Meeting of Shifa International Hospitals Ltd held on June 15, 2024 | View PDF |
Jun 14, 2024 | Board Meeting Other Than Financial Results | View PDF |
May 27, 2024 | Notice of Extraordinary General Meeting - Newspaper Clippings | View PDF |
May 24, 2024 | Notice of Extraordinary General Meeting | View PDF |
Apr 17, 2024 | Board Meeting | View PDF |
Date | Title | Document |
---|---|---|
Nov 20, 2024 | Corporate Briefing Session 2024 | View PDF |
Nov 8, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
Nov 6, 2024 | Credit of Final Cash Dividend (D-26) through Electronic Mode | View PDF |
Nov 5, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
Nov 5, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
Nov 1, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
Oct 14, 2024 | CORRIGENDUM TO THE ANNUAL REPORT 2024 | View PDF |
Sep 10, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
Sep 9, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
Sep 5, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
Sep 3, 2024 | Disclosure of Interest by a Director CEO, or Executive of a listed company and their Spouses and the Substantial Shareholders u/c 5.6.1.(d) of PSX Regulations | View PDF |
Financials
All numbers in thousands (000's) except EPS
2024 | 2023 | 2022 | 2021 | |
---|---|---|---|---|
Sales | 23,563,840 | 19,721,425 | 16,197,551 | 14,219,718 |
Profit after Taxation | 1,362,074 | 1,181,406 | 1,162,549 | 699,924 |
Q1 2025 | Q3 2024 | Q2 2024 | Q1 2024 | |
---|---|---|---|---|
Sales | 7,061,368 | 5,783,320 | 6,078,400 | 5,941,386 |
Profit after Taxation | 628,675 | 321,738 | 351,100 | 393,542 |
Ratios
2024 | 2023 | 2022 | 2021 | |
---|---|---|---|---|
Gross Profit Margin (%) | 100.00 | 100.00 | 100.00 | 100.00 |
Net Profit Margin (%) | 5.78 | 5.99 | 7.18 | 4.92 |
EPS Growth (%) | 15.30 | 1.63 | 66.12 | 35.33 |
PEG | 0.44 | 4.02 | 0.15 | 0.56 |
Payouts
Date | Financial Results | Details | Book Closure |
---|---|---|---|
September 16, 2024 3:51 PM | 30/06/2024(YR) | 25%(F) (D) | 19/10/2024 - 28/10/2024 |
April 26, 2024 3:29 PM | 31/03/2024(IIIQ) | 15%(i) (D) | 10/05/2024 - 12/05/2024 |
October 2, 2023 3:18 PM | 30/06/2023(YR) | 15%(F) (D) | 20/10/2023 - 27/10/2023 |
September 29, 2022 11:28 AM | 30/06/2022(YR) | 15%(F) (D) | 21/10/2022 - 28/10/2022 |
April 28, 2022 12:49 PM | 31/03/2022(IIIQ) | 15% (D) | 12/05/2022 - 14/05/2022 |
September 27, 2021 12:37 PM | 30/06/2021(YR) | 2% (B) | 21/10/2021 - 28/10/2021 |
September 16, 2019 2:13 PM | 30/06/2019(YR) | 25.5% (F) (D) | 19/10/2019 - 26/10/2019 |
September 10, 2018 9:50 AM | 30/06/2018(YR) | 45% (D) | 18/10/2018 - 27/10/2018 |
September 12, 2017 9:54 AM | 30/06/2017(YR) | 50% (D) | 18/10/2017 - 27/10/2017 |
August 25, 2016 3:21 PM | 30/06/2016(YR) | 30% (D) | 22/10/2016 - 29/10/2016 |